Skip to main content
SB

SynThera Biomedical

The startup develops specialty glass materials designed for bone tissue regeneration therapies, enabling healthcare professionals to utilize glass-based biomaterials in regenerative medicine. Their products provide affordable solutions that meet the stringent requirements of high-tech applications in the pharmaceutical and FMCG sectors.

Pune, IndiaFounded 201571K+ followers
Updated 18 months ago

Funding

$330K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

1BI
Funding rounds are not available yet.

Founders

Product

Problem

Current methods for bone and tissue regeneration often rely on materials that lack the necessary biocompatibility and bioactivity to effectively integrate with the body's natural healing processes. This can lead to slower healing times, increased risk of complications, and suboptimal regenerative outcomes. Furthermore, existing solutions may not always be affordable or readily customizable to meet specific clinical needs.

Solution

Synthera develops and manufactures bioactive glass materials designed to enhance bone and tissue regeneration across a range of medical applications. Their products, including Porosyn and Therasenz, are formulated to mimic the composition of natural bone, promoting faster and more effective healing. Porosyn is a family of tissue repair and regeneration products optimized to release elements naturally present in human bone at rates that provide optimum osteostimulation. Therasenz, a 45S5 Bioglass, has demonstrated abilities to repair and regenerate tissues such as bone, dental enamel and skin. Synthera's bioactive glasses can be customized in terms of composition, porosity, and particle size to meet the specific requirements of diverse applications, from bone grafts and dental fillings to cosmetics and disinfection.

Target Audience

Synthera's primary customers include clinicians performing dental, maxillofacial, and orthopedic surgeries, as well as companies in the pharmaceutical, medical device, cosmetics, FMCG, and water treatment industries.

Features

  • Porosyn bioactive glass with a composition optimized for osteostimulation and bone regeneration
  • Therasenz 45S5 Bioglass for bone, dental enamel, and skin repair
  • Customizable particle sizes (from coarse to micron-fine) for powdered glass products
  • Capability to produce frit and cullet with tailored physical properties
  • Disinfectant glass formulations providing long-term disinfection via controlled ion release and pH modulation
  • Production using both crucible and day tank furnaces for highly customized glass compositions
  • Granules and blocks with customizable sizes for ease of handling in surgical procedures
This profile is AI-generated and may contain inaccuracies.